University of California San Francisco
Give to UCSF
Kristine Yaffe shares what scientists are learning about the long-term consequences of traumatic brain injury.
Amanda Woerman explores how basic science fuels efforts to end trauma-induced brain disease.
More than half of TBI patients are over 65 – research hasn’t caught up to the demographic shift.
Millions of people suffer traumatic brain injuries each year, but there remains no effective treatment.
UCSF: The Campaign is taking on the world’s most complex health challenges, powered by an exceptional community of mavericks, innovators, and advocates. Together we will make the Bay Area and our world healthier for all.
UCSF physician-scientists have developed a test that can predict how patients with juvenile myelomonocytic leukemia will respond to treatment.
An easy-to-use tool to predict the likelihood of a child with kidney disease progressing to kidney failure has a high degree of accuracy.
Researchers said all the groups in the study – black, white and Hispanic – reported high rates of discrimination for one reason or another.
Whether you are seeing them for the first time or coming back for another look, check out the most popular scientific stories from UC San Francisco from the past year.
UCSF have taken the first step toward a comprehensive atlas of gene expression in cells across the developing human brain.
Researchers at UCSF have developed a new genetic model of autism, using neurons created in the lab from patients’ own skin cells.
Children with an extremely deadly form of brain cancer might benefit from a new treatment that aims to direct an immune response against a mutant form of a protein found exclusively on cancer cells.
Peter Walter, PhD, professor of biochemistry and biophysics at UCSF, has been named winner of a 2018 Breakthrough Prize in Life Sciences, for his research on a biological mechanism that normally protects cells, but can cause disease if not functioning properly.
Maternal stress during the second trimester of pregnancy may influence the nervous system of the developing child, both before and after birth.
A tiny implant developed in the lab of Tejal Desai promises to simplify how glaucoma drugs are administered, making life easier for aging patients.